IBIO-600

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameIBIO-600
Drug Alias NameIBIO-600
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstralBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesIbio Inc
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A